Key Takeaways
- •Specialty & Focus：Regenerative Medicine — specializing in Cancer immunotherapy consultation, Immune support, Aesthetic and skin-cell treatment
- •Core Features：OMM Building 9F status after Keihan/Kobe consolidation requires confirmation, Cancer immunotherapy consultation
- •Location：Located in Otemae, Chuo-ku, Osaka
- •Coordination Relationship：Case-by-case coordination
About This Hospital
The Saisei Mirai official site lists self-pay categories including cancer immunotherapy, immune support, and aesthetic or skin-cell treatments, and notes that the Keihan and Kobe locations have been consolidated into the OMM Building 9F in Osaka. GcMAF, JG-1, ECCT, and photo/sonodynamic approaches are treated here as official or legacy technical background requiring current confirmation, not as guaranteed or fixed current therapies.
Medical Features & Strengths
- OMM Building 9F status after Keihan/Kobe consolidation requires confirmation
- Cancer immunotherapy consultation
- Immune-support consultation
- Aesthetic and skin-cell treatment categories
- GcMAF / JG-1 and related items require current confirmation
- Founder Dr. Toshio Inui
Departments & Specialties
Public Doctor Profiles
These profiles are shown only when public photos and profile data are already available. The attending physician, schedule, and acceptance conditions must still be confirmed with the clinic.
Inui Toshio
Chairperson
Saisei Mirai Group
Detailed Information
Saisei Mirai Medical Group has legacy and current materials related to cancer immunity, immune support and regenerative-medicine consultation. This page treats several older items as topics requiring current confirmation.
Branch status, clinic consolidation, cancer immune therapy, GcMAF/MAF macrophage activation materials, JG-1 gene therapy and photo/ultrasound dynamic approaches should be checked against current official pages before use.
Current positioning
Branch status, clinic consolidation, cancer immune therapy, GcMAF/MAF macrophage activation materials, JG-1 gene therapy and photo/ultrasound dynamic approaches should be checked against current official pages before use.
Branch status and current confirmation
Branch status, clinic consolidation, cancer immune therapy, GcMAF/MAF macrophage activation materials, JG-1 gene therapy and photo/ultrasound dynamic approaches should be checked against current official pages before use.
Cancer immune-therapy items
Branch status, clinic consolidation, cancer immune therapy, GcMAF/MAF macrophage activation materials, JG-1 gene therapy and photo/ultrasound dynamic approaches should be checked against current official pages before use.
If standard treatment remains indicated, this page should not encourage delaying or stopping it. Discussion should start from the existing medical record, the treating physician's plan, imaging and the patient's general condition.
GcMAF / MAF and macrophage activation information
Use the current official group website, Keihan Clinic page, Kobe clinic relocation/merger information and doctor pages as the starting point for confirmation.
JG-1 gene therapy and photo/ultrasound dynamic topics
Branch status, clinic consolidation, cancer immune therapy, GcMAF/MAF macrophage activation materials, JG-1 gene therapy and photo/ultrasound dynamic approaches should be checked against current official pages before use.
If standard treatment remains indicated, this page should not encourage delaying or stopping it. Discussion should start from the existing medical record, the treating physician's plan, imaging and the patient's general condition.
Dr. Toshio Inui and research activity
Doctor information should stay limited to current official pages and reliable listings. Do not add degrees, roles, case numbers or academic titles that are not confirmed.
Basic information
Use the current official group website, Keihan Clinic page, Kobe clinic relocation/merger information and doctor pages as the starting point for confirmation.
Compliance reminder
Legacy GcMAF, gene-therapy or dynamic-therapy wording must not be reused as a current treatment promise without clinic confirmation and risk/fee documentation.
References
Frequently Asked Questions
What are the specialties and features of Saisei Mirai Group?
Saisei Mirai Group is a medical institution specializing in Regenerative Medicine. Key features include: OMM Building 9F status after Keihan/Kobe consolidation requires confirmation, Cancer immunotherapy consultation, Immune-support consultation, Aesthetic and skin-cell treatment categories, GcMAF / JG-1 and related items require current confirmation, Founder Dr. Toshio Inui.
How can international patients book an appointment or second opinion at Saisei Mirai Group?
International patients should first organize their records through a medical coordination agency such as Medical Supporter and confirm acceptance with the clinic. Documents, interpretation, visa support and fees are checked case by case.